1. 4β‐Hydroxycholesterol as an Endogenous Biomarker for CYP3A Activity: Literature Review and Critical Evaluation. (12th February 2019) Authors: Penzak, Scott R.; Rojas‐Fernandez, Carlos Journal: Journal of clinical pharmacology Issue: Volume 59:Number 5(2019) Page Start: 611 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Antiretroviral Boosting Agent Cobicistat Increases the Pharmacokinetic Exposure and Anticoagulant Effect of Dabigatran in HIV-Negative Healthy Volunteers. Issue 23 (6th December 2016) Authors: Gordon, Lori A.; Kumar, Parag; Brooks, Kristina M.; Kellogg, Anela; McManus, Maryellen; Alfaro, Raul M.; Nghiem, Khanh; George, Jomy M.; Lozier, Jay; Penzak, Scott R.; Hadigan, Colleen Journal: Circulation Issue: Volume 134:Issue 23(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical Pharmacology of the Dietary Supplement Kratom (Mitragyna speciosa). (5th January 2022) Authors: Hartley, Chad; Bulloch, Marilyn; Penzak, Scott R. Journal: Journal of clinical pharmacology Issue: Volume 62:Number 5(2022) Page Start: 577 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Emerging drugs and vaccines for Candidemia. Issue 12 (8th October 2014) Authors: Moriyama, Brad; Gordon, Lori A.; McCarthy, Matthew; Henning, Stacey A.; Walsh, Thomas J.; Penzak, Scott R. Journal: Mycoses Issue: Volume 57:Issue 12(2014) Page Start: 718 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Impact of team‐based care on appropriate statin therapy prescribing in ***HIV‐infected patients. Issue 3 (28th January 2020) Authors: Hester, Elizabeth K.; Caulder, Celeste R.; Penzak, Scott R. Journal: Journal of the American College of Clinical Pharmacy Issue: Volume 3:Issue 3(2020) Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Influence of Panax ginseng on the Steady State Pharmacokinetic Profile of Lopinavir‐Ritonavir in Healthy Volunteers. Issue 11 (20th August 2014) Authors: Calderón, Mónica M.; Chairez, Cheryl L.; Gordon, Lori A.; Alfaro, Raul M.; Kovacs, Joseph A.; Penzak, Scott R. Journal: Pharmacotherapy Issue: Volume 34:Issue 11(2014) Page Start: 1151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Lack of an Effect of Ritonavir Alone and Lopinavir‐Ritonavir on the Pharmacokinetics of Fenofibric Acid in Healthy Volunteers. Issue 1 (January 2016) Authors: Gordon, Lori A.; Malati, Christine Y.; Hadigan, Colleen; McLaughlin, Mary; Alfaro, Raul M.; Calderón, Mónica M.; Kovacs, Joseph A.; Penzak, Scott R. Journal: Pharmacotherapy Issue: Volume 36:Issue 1(2016) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Midazolam Single Time Point Concentrations to Estimate Exposure and Cytochrome P450 (CYP) 3A Constitutive Activity Utilizing Limited Sampling Strategy With a Population Pharmacokinetic Approach. (17th April 2018) Authors: Yang, Jincheng; Patel, Maulik; Nikanjam, Mina; Capparelli, Edmund V.; Tsunoda, Shirley M.; Greenberg, Howard E.; Penzak, Scott R.; Aubrey Stoch, S.; Bertino, Joseph S.; Nafziger, Anne N.; Ma, Joseph D. Journal: Journal of clinical pharmacology Issue: Volume 58:Number 9(2018) Page Start: 1205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pharmacokinetics of Intravenous Voriconazole in Obese Patients: Implications of CYP2C19 Homozygous Poor Metabolizer Genotype. Issue 3 (11th February 2013) Authors: Moriyama, Brad; Jarosinski, Paul F.; Figg, William D.; Henning, Stacey A.; Danner, Robert L.; Penzak, Scott R.; Wayne, Alan S.; Walsh, Thomas J. Journal: Pharmacotherapy Issue: Volume 33:Issue 3(2013) Page Start: e19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Response to "Impact of CYP3A4 Genotype on Voriconazole Exposure: New Insights Into the Contribution of CYP3A4*22 to Metabolism of Voriconazole". Issue 2 (16th November 2017) Authors: Walsh, Thomas J.; Moriyama, Brad; Penzak, Scott R.; Klein, Teri E.; Caudle, Kelly E. Journal: Clinical pharmacology & therapeutics Issue: Volume 103:Issue 2(2018) Page Start: 187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗